VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 165 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,717 | -34.4% | 7,342 | 0.0% | 0.00% | – |
| Q2 2023 | $48,384 | -2.9% | 7,342 | 0.0% | 0.00% | – |
| Q1 2023 | $49,852 | -8.1% | 7,342 | 0.0% | 0.00% | – |
| Q4 2022 | $54,257 | -25.7% | 7,342 | 0.0% | 0.00% | – |
| Q3 2022 | $73,000 | -8.8% | 7,342 | 0.0% | 0.00% | – |
| Q2 2022 | $80,000 | -3.6% | 7,342 | 0.0% | 0.00% | – |
| Q1 2022 | $83,000 | -27.8% | 7,342 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $115,000 | +17.3% | 7,342 | +28.0% | 0.00% | 0.0% |
| Q3 2021 | $98,000 | -22.2% | 5,736 | -40.1% | 0.00% | 0.0% |
| Q4 2020 | $126,000 | +37.0% | 9,575 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $92,000 | -16.4% | 9,575 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $110,000 | +175.0% | 9,575 | +147.0% | 0.00% | – |
| Q1 2020 | $40,000 | -37.5% | 3,876 | 0.0% | 0.00% | – |
| Q4 2019 | $64,000 | +25.5% | 3,876 | 0.0% | 0.00% | – |
| Q3 2019 | $51,000 | -7.3% | 3,876 | 0.0% | 0.00% | – |
| Q2 2019 | $55,000 | -22.5% | 3,876 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $71,000 | -29.7% | 3,876 | +0.5% | 0.00% | 0.0% |
| Q4 2018 | $101,000 | +14.8% | 3,855 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $88,000 | +33.3% | 3,855 | +11.2% | 0.00% | 0.0% |
| Q2 2018 | $66,000 | +153.8% | 3,467 | +127.0% | 0.00% | – |
| Q1 2018 | $26,000 | +13.0% | 1,527 | 0.0% | 0.00% | – |
| Q4 2017 | $23,000 | -14.8% | 1,527 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | +8.0% | 1,527 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | +19.0% | 1,527 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | -12.5% | 1,527 | 0.0% | 0.00% | – |
| Q4 2016 | $24,000 | -4.0% | 1,527 | 0.0% | 0.00% | – |
| Q3 2016 | $25,000 | +108.3% | 1,527 | +47.7% | 0.00% | – |
| Q2 2016 | $12,000 | +33.3% | 1,034 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -10.0% | 1,034 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -16.7% | 1,034 | 0.0% | 0.00% | – |
| Q3 2015 | $12,000 | – | 1,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |